Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients

Abstract

Background: Little is known about the predictive role of Cardiac Self Efficacy (CSE) in the ensuing months following a coronary event. We sought to determine whether CSE predicts adverse events in the months following discharge in patients with Coronary Artery Disease (CAD). Design: Data from a prospective study of 193 patients recently hospitalized for CAD. Methods: Data were collected via participant self-report and medical records at 3-month post-discharge (baseline; T1), 6-month post-discharge (T2) and 9-month post-discharge (T3). CSE was measured using the Cardiac Self Efficacy Scale. Multi-variate regression modeling was applied to explore the association between baseline CSE scores and cardiac-related hospital admissions and functional cardiac status at T2 and T3. Other outcomes included any hospital admissions, self-reported mental and physical health at follow up. Results: Higher CSE scores at baseline significantly predicted better cardiac functioning and self-rated mental and physical health at both T2 and T3 (with one exception); this was consistent across all five models. While baseline CSE did not predict cardiac or other hospital admission at T2, CSE was a significant predictor of both outcomes at T3; higher CSE scores resulted in reductions in likelihood of hospital admissions. After adjustment for psychosocial variables however, neither association remained. Baseline depression explained the association between baseline CSE and any cardiac admissions, as well as baseline CSE and any hospital admissions at T3 follow up. Conclusions: While CSE can predict key outcomes following a CAD event, much of the association can be explained by the presence of depression.

Effects of a peer education on cardiac self‐efficacy and readmissions in patients undergoing coronary artery bypass graft surgery: a randomized‐controlled trial

“…Cardiac Self-efficacy (CSE) is in fact a cardiac-specific measure of one's belief regarding his/her ability to perform activities related to the symptoms and challenges of CVD (O'Neil et al, 2013). For those who suffer from CAD, self-efficacy is an efficient tool for the prediction of readmission chance (Sarkar et al, 2009;Negarandeh et al, 2012).…”

Patients’ Cardiac Self-Efficacy After Coronary Artery Angioplasty

“…Cardiac self-efficacy motivates the individuals to select a lifestyle about their cardiovascular disease via creating enthusiasm to adjust with such behaviors (14). The studies indicated that the individuals with high self-confidence actively participate in health promoting health plans (4,16).…”

“…Cardiac self-efficacy is indeed an exclusive cardiac scale about an individual's belief about his capabilities to do the activities related to CAD symptoms and challenges (1,14,17). Cardiac self-efficacy motivates the individuals to select a lifestyle about their cardiovascular disease via creating enthusiasm to adjust with such behaviors (14).…”

“…Generally speaking, working on promoting self-efficacy and empowering them is important in self-care regimen follow-up through selfefficacy promotion (13). It is depicted that self-efficacy affects health and health-related outcomes based on the behaviors in treating the patients with chronic diseases and is considered as one of the most significant predictors of behavioral modifications in the patients (4,14,15). On the other hand, self-efficacy is directly associated with healthy behaviors and indirectly influences healthy behaviors to achieve the goals, the challenges the individuals are facing and perseverance, commitment and effort to reach the goal (16).…”

Randomized controlled trial of a self‐efficacy enhancement program for the cardiac rehabilitation of Thai patients with myocardial infarction

“…A new approach to CR programs, therefore, should be multidimensional and take into account psychosocial factors. Such factors, including self-efficacy and family support, have been shown to be important predictors of the functional status of patients with cardiac disease (Sarkar et al, 2007;Tziallas & Tziallas, 2010;Brink et al, 2012;O'Neil et al, 2013;Shin et al, 2013).…”